Cerebras vs. SpaceX: Which Is the Better AI IPO Stock to Buy and Hold for the Next 10 Years?

The article compares Cerebras and SpaceX as newly public AI-linked growth stories, concluding SpaceX is the stronger 10-year pick due to Starlink’s $18.7 billion 2025 revenue base, $4.4 billion in operating profit, and multiple growth engines. Cerebras posted 2025 revenue of $510 million, up 75.7%, but trades at 90.2x trailing sales and remains highly dependent on OpenAI-related demand and execution. The piece is largely opinion-driven rather than a fresh catalyst, so near-term market impact should be limited.

Analysis

The real takeaway is not “AI chips vs space,” but backlog monetization quality. Both names are effectively pre-positioning future capacity with large counterparties, yet the valuation gap will be decided by how much of that backlog converts into repeatable gross profit rather than headline revenue. In that framework, GOOGL and AMZN are the more important second-order beneficiaries than the pure plays: they gain lower-latency AI supply optionality without owning the full buildout risk, and they can arbitrage capacity across customers if one program slips.

Cerebras’ key fragility is customer concentration plus execution asymmetry. When a single anchor customer becomes both the demand engine and the financing source, any delay turns from “growth miss” into a financing event, because capex has to precede revenue recognition. That creates a near-term setup where the stock can continue to rerate on announced capacity, but the first operational hiccup could compress multiple simultaneously—especially if hyperscaler alternatives or custom silicon reduce the need for specialized inference hardware.

SpaceX looks structurally better, but the market is probably underestimating how much of the AI upside is still a call option on Starship reliability and power delivery. The important catalyst window is 6-18 months: if launch cadence and data-center throughput improve, the company can broaden from connectivity into a platform with multiple monetization layers; if not, the AI narrative remains capital-intensive and discount-rate sensitive. The counterintuitive risk is that success in satellite broadband may actually slow margin expansion by funding more low-return expansion before the AI business is fully proven.

Consensus is likely overpaying for the idea that every AI infrastructure winner will be judged like Nvidia. The more durable winners here are the platform owners with embedded distribution and financing advantages, while the pure-play compute vendor is the more binary outcome. In other words, the market may be underweight the probability that GOOGL and AMZN capture the economically attractive parts of the value chain while offloading construction and utilization risk to partners.

Key Decisions for Investors

• Long GOOGL vs. CBRS on a 3-6 month horizon: own the customer-distribution layer over the single-node hardware exposure. Risk/reward favors GOOGL if one major contract slips, because downside is buffered by diversified cash flows while CBRS is multiple-sensitive to delivery execution.
• Buy AMZN into any pullback over the next 1-2 quarters as a cleaner way to express AI inference demand through AWS channels. The thesis works if inference adoption broadens, but risk is capped versus a direct hardware bet because AMZN monetizes usage, not factory buildout.
• Initiate a small tactical long in SPCX on weakness, but hedge with lower-risk capital structure exposure elsewhere. The setup is attractive over 12-24 months, yet the position should be sized like an execution call option given capex intensity and delivery risk.
• Short-dated put spread on CBRS around the next major delivery checkpoint. The stock can re-rate further on headline contract news, but any slippage in capacity ramp or service levels should force a fast de-rating; structure for asymmetric downside rather than outright shorting.
• Monitor NVDA as the implied loser only if alternative inference stacks start proving superior latency/cost in production. For now the better trade is not to short NVDA, but to watch for share capture signs that would validate CBRS as a real competitive threat.